{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:39:30Z","timestamp":1756571970966},"reference-count":32,"publisher":"Edizioni Minerva Medica","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Minerva Ginecol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.23736\/s0026-4784.19.04388-0","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T08:58:27Z","timestamp":1562317107000},"source":"Crossref","is-referenced-by-count":7,"title":["Combined systemic (fluconazole) and topical (metronidazole + clotrimazole) therapy for a new approach to the treatment and prophylaxis of recurrent candidiasis"],"prefix":"10.23736","volume":"71","author":[{"given":"Carlo","family":"Genovese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Corsello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ettore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Mattana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna","family":"Tempera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17149","reference":[{"key":"10.23736\/S0026-4784.19.04388-0_ref001","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2015.1091805"},{"key":"10.23736\/S0026-4784.19.04388-0_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60917-9"},{"key":"10.23736\/S0026-4784.19.04388-0_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.06.067"},{"key":"10.23736\/S0026-4784.19.04388-0_ref004","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e3182241f1a"},{"key":"10.23736\/S0026-4784.19.04388-0_ref005","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski KA","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.23736\/S0026-4784.19.04388-0_ref006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033114"},{"key":"10.23736\/S0026-4784.19.04388-0_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.06.029"},{"key":"10.23736\/S0026-4784.19.04388-0_ref008","doi-asserted-by":"publisher","DOI":"10.1159\/000314022"},{"key":"10.23736\/S0026-4784.19.04388-0_ref009","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2018.1525375"},{"key":"10.23736\/S0026-4784.19.04388-0_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2004.05.008"},{"key":"10.23736\/S0026-4784.19.04388-0_ref011","doi-asserted-by":"crossref","unstructured":"Machado Villa TV, Rozental S. Biofilm Formation as a Pathogenicity Factor of Medically Important Fungi; 2016 [Internet]. Available from: https:\/\/www.intechopen.com\/books\/fungal-pathogenicity\/biofilm-formation-as-a-pathogenicity-factor-of-medically-important-fungi [cited 2019, May 6].","DOI":"10.5772\/62768"},{"key":"10.23736\/S0026-4784.19.04388-0_ref012","first-page":"3336","article-title":"Alterations of the vaginal microbiota in the third trimester of pregnancy and pPROM","volume":"20","author":"Genovese C","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.23736\/S0026-4784.19.04388-0_ref013","first-page":"229","article-title":"Features of vaginal bacterial community in women with recurrent vulvovaginal candidiasis","volume":"26","author":"Shen J","year":"2015","journal-title":"J Reprod Contracept."},{"key":"10.23736\/S0026-4784.19.04388-0_ref014","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.19.2.435-447.2006"},{"key":"10.23736\/S0026-4784.19.04388-0_ref015","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv381"},{"key":"10.23736\/S0026-4784.19.04388-0_ref016","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.000589"},{"key":"10.23736\/S0026-4784.19.04388-0_ref017","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.Supplement_3.S318"},{"key":"10.23736\/S0026-4784.19.04388-0_ref018","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.5.909"},{"key":"10.23736\/S0026-4784.19.04388-0_ref019","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S67776"},{"key":"10.23736\/S0026-4784.19.04388-0_ref020","first-page":"1","article-title":"La sfida terapeutica delle candidosi vulvovaginali ricorrenti","volume":"62","author":"Graziottin A","year":"2010","journal-title":"Minerva Ginecol"},{"key":"10.23736\/S0026-4784.19.04388-0_ref021","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.17.05683-8"},{"key":"10.23736\/S0026-4784.19.04388-0_ref022","first-page":"59","article-title":"Trattamento delle candidosi vaginali con fluconazolo: terapia sistemica versus terapia combinata sistemica e locale","volume":"XXXI","author":"Gentile A","year":"2011","journal-title":"Derm Clin"},{"key":"10.23736\/S0026-4784.19.04388-0_ref023","first-page":"707","article-title":"L'attualit\u00e0 del trattamento topico delle infezioni vaginali con l'associazione metronidazolo-clotrimazolo]","volume":"65","author":"Tavassoli K","year":"2013","journal-title":"Minerva Ginecol"},{"key":"10.23736\/S0026-4784.19.04388-0_ref024","first-page":"172","article-title":"Studio dell'attivit\u00e0 in vitro e in vivo dell'associazione clotrimazolo-metronidazolo: attivit\u00e0 antimicotica e antibatterica in vitro ed efficacia nella terapia delle vaginiti\/vaginosi","volume":"30","author":"Furneri PM","year":"2008","journal-title":"Giorn It Ost Gin"},{"key":"10.23736\/S0026-4784.19.04388-0_ref025","first-page":"443","article-title":"Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream","volume":"41","author":"Ferris DG","year":"1995","journal-title":"J Fam Pract"},{"key":"10.23736\/S0026-4784.19.04388-0_ref026","doi-asserted-by":"publisher","DOI":"10.1086\/647939"},{"key":"10.23736\/S0026-4784.19.04388-0_ref027","first-page":"85","article-title":"Efficacia dell'associazione metronidazolo\/clotrimazolo nella terapia e profilassi delle vulvovaginiti ricorrenti da Candida (RVC).","volume":"26","author":"Nicoletti G","year":"2012","journal-title":"GIMMOC Quaderni di Microbiologia e Clinica"},{"key":"10.23736\/S0026-4784.19.04388-0_ref028","first-page":"75","article-title":"Influenza dell'associazione Clotrimazolo\/ Metronidazolo (1:5) sullo \"Switching\" Fenotipico di C. albicans","volume":"25","author":"Furneri PM","year":"2011","journal-title":"GIMMOC"},{"key":"10.23736\/S0026-4784.19.04388-0_ref029","doi-asserted-by":"publisher","DOI":"10.1111\/jam.13289"},{"key":"10.23736\/S0026-4784.19.04388-0_ref030","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/636474"},{"key":"10.23736\/S0026-4784.19.04388-0_ref031","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010496.pub2"},{"key":"10.23736\/S0026-4784.19.04388-0_ref032","unstructured":"Isenberg HD. Clinical microbiology procedures handbook. Washington: American Society for Microbiology; 2017."}],"container-title":["Minerva Ginecologica"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R09Y2019N04A0321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T06:39:46Z","timestamp":1569911986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R09Y2019N04A0321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":32,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.23736\/s0026-4784.19.04388-0","relation":{},"ISSN":["0026-4784","1827-1650"],"issn-type":[{"value":"0026-4784","type":"print"},{"value":"1827-1650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}